| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/07/1998 | CA2269328A1 Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake |
| 05/07/1998 | CA2269203A1 Substituted tricyclics |
| 05/07/1998 | CA2269095A1 2-pyrimidineamine derivatives and processes for their preparation |
| 05/07/1998 | CA2268942A1 Methods of treating or preventing cardiac arrhythmia |
| 05/07/1998 | CA2268940A1 Integrin antagonists |
| 05/07/1998 | CA2268750A1 Human p2x purinoreceptor |
| 05/07/1998 | CA2268001A1 Circularly permuted erythropoietin receptor agonists |
| 05/07/1998 | CA2241687A1 P2y receptor antagonists |
| 05/07/1998 | CA2241626A1 Riboflavin mutants as vaccines against actinobacillus pleuropneumoniae |
| 05/06/1998 | EP0839910A2 Spo-rel, a Staphylococcus relA/spot homologue |
| 05/06/1998 | EP0839814A2 Indolocarbazole derivatives and their use for the treatment of prostate gland disorders |
| 05/06/1998 | EP0839806A1 Substituted tricyclics |
| 05/06/1998 | EP0839533A1 Methods of preventing breast cancer by the administration of Raloxifene |
| 05/06/1998 | EP0839532A1 Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene |
| 05/06/1998 | EP0839529A2 Compositions containing aliphatic monocarboxylic acid esters or amides for the treatment of skin diseases |
| 05/06/1998 | EP0839196A2 Human ctla-8 and uses of ctla-8-related proteins |
| 05/06/1998 | EP0839194A1 Protein p53 variants and their therapeutic uses |
| 05/06/1998 | EP0839157A1 Colostrum derived growth factor |
| 05/06/1998 | EP0839149A1 Galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 05/06/1998 | EP0839143A1 Tetralin compounds with mdr activity |
| 05/06/1998 | EP0839136A1 BENZO[g]QUINOLINE DERIVATIVES |
| 05/06/1998 | EP0839134A1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 05/06/1998 | EP0839133A1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors |
| 05/06/1998 | EP0839041A1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 05/06/1998 | EP0839033A2 Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral |
| 05/06/1998 | EP0742790A4 Substituted purines and oligonucleotide cross-linking |
| 05/06/1998 | EP0740652B1 Metalloproteinase inhibitors |
| 05/06/1998 | EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 05/06/1998 | CN1181075A Substituted isoxazoles for the treatment of inflammation |
| 05/06/1998 | CN1181070A Bicyclic isothiourea derivatives useful in therapy |
| 05/06/1998 | CN1181066A Arylsulfonylamino hydroxamic acid derivatives |
| 05/06/1998 | CN1181018A 多功能酶 Multifunctional enzyme |
| 05/06/1998 | CN1181014A A pharmaceutical composition containing N-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers |
| 05/06/1998 | CN1181012A Method of lessening the rish of non-vertebral bone fractures |
| 05/06/1998 | CN1181008A Method of lessening the risk of vertebral fractures |
| 05/06/1998 | CN1180709A Neopolynucleotide and polypeptide gene of genetic multiple exogenetic bone wart family |
| 05/06/1998 | CN1180569A Preparation for medicine feeding through nose |
| 05/06/1998 | CN1180532A Chinese drugs for darkening hair and its preparation method |
| 05/05/1998 | US5747663 Process for the depletion or removal of endotoxins |
| 05/05/1998 | US5747646 Polyethylene-protein conjugates |
| 05/05/1998 | US5747541 Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them |
| 05/05/1998 | US5747539 Fluorine-containing benzoylguanidines |
| 05/05/1998 | US5747538 Glucopyranoside for synthesis of collagen |
| 05/05/1998 | US5747535 Selective thrombin inhibitors |
| 05/05/1998 | US5747524 Cannabinoid receptor antagonists |
| 05/05/1998 | US5747514 Metalloproteinase inhibitors |
| 05/05/1998 | US5747513 Hypotensive agents, heart failure and cerebrovascular insufficiency |
| 05/05/1998 | US5747510 Pharmaceutical unit dosage formulations |
| 05/05/1998 | US5747509 Prevention of occlusion in arteries |
| 05/05/1998 | US5747506 Antihistamines, bronchodilator agents; asthma |
| 05/05/1998 | US5747503 Indeno(1,2b)pyroles |
| 05/05/1998 | US5747501 Indole derivatives |
| 05/05/1998 | US5747499 Cyclopentaquinazoline compounds cyclopentaquinazoline compounds |
| 05/05/1998 | US5747496 Inhibitors of platelet aggregation |
| 05/05/1998 | US5747489 Arylalkyl-thiadiazinones |
| 05/05/1998 | US5747488 2-aryl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-E! 1, 4!diazepines and their use in the treatment of HIV infection |
| 05/05/1998 | US5747481 Analgesics and antiinflammaory agents |
| 05/05/1998 | US5747458 Plasminogen activator of protease and tripeptides |
| 05/05/1998 | US5747457 Linear adhesion inhibitors |
| 05/05/1998 | US5747456 Continuous low-dose administration of parathyroid hormone or its agonist |
| 05/05/1998 | US5747318 Mitogen activated c-Fos regulating kinase, FRK |
| 05/05/1998 | US5747307 Mason-Pfizer Monkey Retroviral packaging defective vectors |
| 05/05/1998 | US5747288 Protein kinase required for Ras signal transduction |
| 05/05/1998 | US5747275 Protein kinase required for RAS signal transduction |
| 05/05/1998 | US5747267 Method for identifying a G protein coupled glutamate receptor agonist and antagonist |
| 05/05/1998 | US5747023 Cancer therapy using lymphotoxin |
| 05/05/1998 | CA2152588C Anti-androgenic cyclo and bicyclo alkenes |
| 05/05/1998 | CA2152350C Reduction of hair growth employing sulfhydryl reactive compounds |
| 05/05/1998 | CA2097589C Targeting of therapeutic agents using polysaccharides |
| 04/30/1998 | WO1998017823A1 STRUCTURAL AND FUNCTIONAL CONSERVATION OF THE C. ELEGANS CLOCK GENE $i(clk-1) |
| 04/30/1998 | WO1998017814A2 Gene expression and delivery systems and uses |
| 04/30/1998 | WO1998017797A1 ANTI-ErbB2 ANTIBODIES |
| 04/30/1998 | WO1998017794A1 Human eosinophil-derived basic protein |
| 04/30/1998 | WO1998017686A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | WO1998017672A1 Substituted aminoalkane phosphonic acids |
| 04/30/1998 | WO1998017668A1 Thienopyrimidine with phosphodiesterase v inhibiting effect |
| 04/30/1998 | WO1998017659A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 04/30/1998 | WO1998017655A1 Metalloproteinase inhibitors |
| 04/30/1998 | WO1998017645A1 α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS |
| 04/30/1998 | WO1998017643A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 04/30/1998 | WO1998017325A2 Covalent polar lipid conjugates for targeting |
| 04/30/1998 | WO1998017321A1 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 04/30/1998 | WO1998017314A1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 04/30/1998 | WO1998017304A1 Anti-fibrotic agent assay |
| 04/30/1998 | WO1998017296A1 Hematopoietic function restorative and processed food both containing treated peanut testae |
| 04/30/1998 | WO1998017244A1 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
| 04/30/1998 | WO1998017116A1 Targeted cytotoxic cells |
| 04/30/1998 | WO1998011225A3 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/30/1998 | WO1998004694A3 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | DE19644228A1 Thienopyrimidine Thienopyrimidines |
| 04/30/1998 | CA2269825A1 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 04/30/1998 | CA2269711A1 Anti-fibrotic agent assay |
| 04/30/1998 | CA2269507A1 Targeted cytotoxic cells |
| 04/30/1998 | CA2269283A1 Metalloproteinase inhibitors |
| 04/30/1998 | CA2268749A1 Structural and functional conservation of the c. elegans clock gene clk-1 |
| 04/30/1998 | CA2268418A1 .alpha.-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/30/1998 | CA2268276A1 Gene expression and delivery systems and uses |
| 04/30/1998 | CA2268045A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | CA2268016A1 Human eosinophil-derived basic protein |
| 04/30/1998 | CA2240458A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |